Intraday MarketsStock report · CRL · Charles River Laboratories International, Inc. · Nov 1, 2026
Intraday Markets
Home › Stocks › CRL

CRL Stock: Price, Earnings History and SEC Filings

Charles River Laboratories International, Inc. (CRL) last traded at $359.41, down 4.44% on the latest session and up 21.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $3.02 against an analyst estimate of $2.72, a beat of 11.0%.

$359.41 -4.44%
1 month+21.83%
52-week high$379.63
52-week low$146.20
Volume1.48M
ExchangeNYSE

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

CRL earnings history

QuarterReportedEPSEstimateSurprise
Jun 2026Aug 5, 2026$3.02$2.72+11.03%
Mar 2026May 7, 2026$2.06$1.96+5.10%
Dec 2025Feb 18, 2026$2.39$2.33+2.58%
Sep 2025Nov 5, 2025$2.43$2.32+4.74%

CRL beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.

Latest SEC filings for CRL

SEC filing data is not available right now. You can search for CRL on SEC EDGAR.

CRL news

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. (CRL) is a US-listed public company on NYSE.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed